Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

ConditionParkinson Disease

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorSupernus Pharmaceuticals, Inc.

About this trial

Real-World Participants Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: A Prospective, Phase 4, Multicenter, Observational Study in Parkinson's Disease

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Observational study

Treatment groups

No treatment groups listed

Sponsors and collaborators

Supernus Pharmaceuticals, Inc.

Lead sponsor

Source ClinicalTrials.gov